VOYA Investment Management
CKPT

VOYA Investment Management’s Checkpoint Therapeutics CKPT Stock Holding History

VOYA Investment Management’s Portfolio CKPT Stock Details CKPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,614
Closed -$82K – 2828
2021
Q1 		$82K Buy
2,614
+446
+21% +$14.9K ﹤0.01% 2696
2020
Q4 		$57K Buy
2,168
+705
+48% +$17.8K ﹤0.01% 2645
2020
Q3 		$39K Buy
1,463
+447
+44% +$10.7K ﹤0.01% 2458
2020
Q2 		$20K Sell
1,016
-877
-46% -$16K ﹤0.01% 2498
2020
Q1 		$29K Hold
1,893
– – ﹤0.01% 2564
2019
Q4 		$33K Buy
+1,893
New +$31.7K ﹤0.01% 2659
2019
Q3 		– Sell
-1,686
Closed -$51K – 2555
2019
Q2 		$51K Buy
+1,686
New +$66.2K ﹤0.01% 2561

Other funds holding CKPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JSMC
Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SAG
Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FWM
Frontier Wealth Management Kansas City, Missouri $1.38B AUM 6.3% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return

VOYA Investment Management's CKPT Position: Q2 2021 in Review

VOYA Investment Management sold out of Checkpoint Therapeutics (CKPT) in Q2 2021, closing a stake of 2,614 shares — an estimated $82K sold.

VOYA Investment Management first reported a position in CKPT in Q2 2019 and held it in 7 quarters. The position peaked at $82K in Q1 2021. 69 funds tracked by Wall St. Rank hold CKPT as of Q2 2021.

  • VOYA Investment Management reported no remaining Checkpoint Therapeutics position as of Q2 2021 after selling out during the quarter.
  • VOYA Investment Management sold 2,614 Checkpoint Therapeutics shares in Q2 2021, an estimated $82K.
  • VOYA Investment Management first reported a position in Checkpoint Therapeutics in Q2 2019 and held it in 7 quarters.
  • VOYA Investment Management's Checkpoint Therapeutics position peaked at $82K in Q1 2021.
  • 69 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2021.

Based on VOYA Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.